Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for MacroGenics, Inc. (MGNX : NSDQ)
 
 • Company Description   
MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics Inc. is headquartered in Rockville, Maryland.

Number of Employees: 341

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.46 Daily Weekly Monthly
20 Day Moving Average: 2,554,511 shares
Shares Outstanding: 63.09 (millions)
Market Capitalization: $92.11 (millions)
Beta: 1.59
52 Week High: $5.77
52 Week Low: $0.99
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -17.98% -21.62%
12 Week 13.18% -3.33%
Year To Date -55.08% -57.92%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
9704 MEDICAL CENTER DRIVE
-
Rockville,MD 20850
USA
ph: 301-251-5172
fax: 301-251-5321
info@macrogenics.com http://www.macrogenics.com
 
 • General Corporate Information   
Officers
Scott Koenig - Chief Executive Officer;President and Director
James Karrels - Senior Vice President;Chief Financial Officer and
Beth Smith - Vice President; Controller and Treasurer
Karen Ferrante - Director
William Heiden - Director

Peer Information
MacroGenics, Inc. (BJCT)
MacroGenics, Inc. (CADMQ)
MacroGenics, Inc. (APNO)
MacroGenics, Inc. (UPDC)
MacroGenics, Inc. (IMTIQ)
MacroGenics, Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 556099109
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/05/25
Share - Related Items
Shares Outstanding: 63.09
Most Recent Split Date: (:1)
Beta: 1.59
Market Capitalization: $92.11 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.40 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-2.04 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/05/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.16
Price/Cash Flow: -
Price / Sales: 0.60
EPS Growth
vs. Year Ago Period: 22.62%
vs. Previous Quarter: -160.00%
Sales Growth
vs. Year Ago Period: 44.90%
vs. Previous Quarter: -31.83%
ROE
06/30/25 - -
03/31/25 - -59.84
12/31/24 - -66.95
ROA
06/30/25 - -
03/31/25 - -23.45
12/31/24 - -27.46
Current Ratio
06/30/25 - -
03/31/25 - 3.28
12/31/24 - 3.92
Quick Ratio
06/30/25 - -
03/31/25 - 3.11
12/31/24 - 3.92
Operating Margin
06/30/25 - -
03/31/25 - -36.23
12/31/24 - -44.65
Net Margin
06/30/25 - -
03/31/25 - -36.23
12/31/24 - -44.65
Pre-Tax Margin
06/30/25 - -
03/31/25 - -35.62
12/31/24 - -44.03
Book Value
06/30/25 - -
03/31/25 - 1.25
12/31/24 - 1.85
Inventory Turnover
06/30/25 - -
03/31/25 - 4.52
12/31/24 - 8.77
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
Debt-to-Capital
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
 

Powered by Zacks Investment Research ©